FierceBiotech

FDA Approves AVONEX® PEN™ and Dose Titration Regimen

Dosing Enhancements May Improve Treatment Experience for Patients Receiving AVONEX® (interferon beta-1a) for Multiple Sclerosis WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) ...
FierceBiotech

Using Avonex Versus Sub-cutaneous Interferon

CAMBRIDGE, Mass.-(BUSINESS WIRE) - Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...
FiercePharma

Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN

-- First single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX recommended for approval in the European Union and authorised in Canada -- AVONEX PEN is designed ...
Monthly Prescribing Reference

Avonex Pen and New Dose Titration Regimen Available

AVONEX PEN (interferon beta-1a) 30mcg/0.5mL solution for injection by Biogen Idec The Avonex Pen (interferon beta-1a 30mcg/0.5mL solution for injection), the first IM autoinjector for chronic use in ...